Biotech policy, regulations & bioethics form the foundational framework that ensures responsible innovation in biotechnology. As advances in genetic editing, synthetic biology, and personalized medicine accelerate, regulatory agencies and global policymakers face the challenge of balancing innovation with public safety and ethical integrity. This field encompasses the formulation of guidelines governing clinical trials, intellectual property, environmental release, and cross-border biotech trade. Bioethics plays a critical role in addressing concerns surrounding genome editing, data privacy, consent in biobanking, and equity in access to biotech products. Biotech policy, regulations & bioethics ensure transparency, accountability, and societal trust while facilitating global collaboration. A well-regulated landscape not only protects public interests but also accelerates adoption of life-enhancing technologies in healthcare, agriculture, and the environment.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Comparative study of endo-?-1,4-mannanases from novel bacterial strains for the production of galactomanno-oligosaccharides
Shruti Saini, National Agri-food and Bio-manufacturing Institute, India
Title : Engineering Sf9 host cells with AcMNPV genes to control baculovirus infection dynamics and heterologous gene expression
Tamer Z Salem, Zewail City of Science and Technology, Egypt